The Business Research Company published its Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Pharmaceutical Contract Development And Manufacturing Organization (CMO) market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers
the Pharmaceutical CMO market’s segments-
By Type: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing, Secondary Packaging.
View Complete Report:
Pharmaceutical Contract Development And
Manufacturing Organization (CMO) Global Market Report 2020 is the most
comprehensive report available on this market and will help gain a truly global perspective as it covers 60
geographies. The chapter on the impact of COVID-19 gives valuable insights on
supply chain disruptions, logistical challenges, and other economic
implications of the virus on the market. The chapter also covers markets which
have been positively affected by the pandemic.
The global pharmaceutical contract
development and manufacturing market is expected to decline from $99.8 billion
in 2019 to $93 billion in 2020 at a compound annual growth rate (CAGR) of -7%.
The decline is mainly due to the focus on COVID-19 outbreak and its treatment
across the globe, and disruption in the supply chain owing to geographical
trade barriers affecting the supply of APIs and raw materials for drug
manufacturing. Sponsors contracting CMOs are pausing the drug development
activities due to COVID-19 or restructuring the current drug development plans.
The market is then expected to recover and reach $128.4 billion in 2023 at a
CAGR of 6.5%.
Companies in the pharmaceutical CMO market
are investing towards acquiring and forming alliances with other companies in
the market. The pharmaceutical CMO companies are following the trend of merger
and acquisition in order to expand their global market reach to meet client
needs, to increase their production capabilities while maintaining cost
efficiencies and to get access to latest technology and new services. The high
level of merger and acquisition activities are resulting in consolidation of
the contract service providers.
Few Points From Table Of Content
1. Executive
Summary
2. Report Structure
3. Pharmaceutical Contract Development And Manufacturing Organization (CMO)
Market Characteristics
4. Pharmaceutical Contract Development And Manufacturing Organization (CMO)
Market Product Analysis
5. Pharmaceutical Contract Development And Manufacturing Organization (CMO)
Market Supply Chain
……
25. Pharmaceutical Contract Development And Manufacturing Market Competitive
Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And
Manufacturing Market
27.
Pharmaceutical Contract Development And Manufacturing Market Trends And
Strategies
28.
Pharmaceutical Contract Development And Manufacturing Market Future Outlook and
Potential Analysis
29. Appendix
Request A Sample Report At:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp
Table 1: Global Historic Market Growth, 2015-2019, $
Billion
Table 2: Global Forecast Market Growth,
2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global Pharmaceutical Contract
Development And Manufacturing Market, Segmentation By Type, Historic and
Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 4: Global Pharmaceutical Contract
Development And Manufacturing Market, Split By Region, Historic and Forecast,
2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 5: Global Pharmaceutical Contract
Development And Manufacturing Market, Split By Country, Historic and Forecast,
2015-2019, 2023F, 2025F, 2030F, $ Billion
……..
Table 25: Recipharm AB Financial Performance
Table 26: Pfizer Inc. Financial Performance
Table 27: Catalent Pharma Solutions
Financial Performance
Table 28: Aenova Group Financial
Performance
Table 29: Famar Financial Performance
About
The Business Research Company:
The Business Research Company is a Business Intelligence Company which
excels in company, market and consumer research. It has offices in the UK, the
US and India and a network of trained researchers in 15 countries
globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
No comments:
Post a Comment